journeymedicalcorp.com - Wutah dodolan YoY (TTM) DERM

Journey Medical focuses on acne and rosacea therapies, capturing the medico-cosmetic niche. This results in moderate pricing power limited by generics, as clearly illustrated by the rolling year-over-year revenue growth chart. The value 17.10 shows the current metric value. Approved drugs and physician trust ensure sales stability, completing the overall business picture.
Journey Medical Corporation - rincian analitis lan metrik utama (DERM)

Steady sales of dermatological products and the implementation of new software drive current operational growth for Journey Medical (DERM). An analysis of relative sales growth over a 12-month period compared to the previous year, utilizing a daily TTM recalculation, neutralizes quarterly gaps, allowing investors to distinguish genuine business strengthening from stagnation and assess revenue sustainability with marketing costs already priced in by the market.